2024 Homecare Personal care 
Hospice News
DECEMBER 9, 2024
Meanwhile, Addus HomeCare Corporation (Nasdaq: ADUS) and Gentiva also completed one of the largest deals of the year. Addus earlier this month closed a $350 million acquisition of Gentivas personal care business. Doulas can help foster collaborative, goal-concordant care as well as improve quality, according to some hospices.
Hospice News
DECEMBER 2, 2024
Addus HomeCare Corporation (Nasdaq: ADUS) has closed its $350 million acquisition of Gentiva’s personal care business. Gentiva’s personal care segment brings in annual revenues of close to $280.0 Notably, we will now be the largest provider of personal care services in the state of Texas,” Allison said. “We
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
JANUARY 31, 2025
Among 112 hospice professionals who responded to the 2024 Outlook Survey by Hospice News and Homecare Homebase, 60% said that expanding current locations would be the growth tactic they plan to use the most during 2025. Hospices in 2025 are laser-focused on organic growth rather than other tactics like acquisitions.
Hospice News
NOVEMBER 5, 2024
Addus HomeCare Corporation (Nasdaq: ADUS) may slow down on mergers and acquisitions in the near term as it absorbs Gentiva’s personal care business. Addus provides personal care, home health and hospice to more than 48,500 patients across 22 states. million in the Q3 of 2024, a 7% year-over-year increase.
Hospice News
MAY 7, 2024
Addus HomeCare Corp. The company is seeking to pair its clinical services with its personal business in its existing markets. The personal care, hospice and home health provider is no stranger to acquisitions. The post Addus HomeCare Expects 2024 Acquisitions appeared first on Hospice News.
Hospice News
OCTOBER 31, 2023
Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. NASDAQ: ADUS) remains on the hunt.
Hospice News
JANUARY 19, 2024
Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. NYSE: HUM) for $2.8
Expert insights. Personalized for you.
265 
Let's personalize your content